Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5415]
News [12565]
Articles [169]
Editorials [5]
Conferences [246]
elearning [17]
Romidepsin treatment in peripheral T cell lymphoma and subsets
Dr Francine Foss – Yale School of Medicine, Connecticut, USA
Romidepsin treatment in peripheral T cell lymphoma and subsets ( Dr Francine Foss – Yale School of Medicine, Connecticut, USA )
19 Dec 2011
Long term effects oophorectomy, at a young age, on bone health
Dr Anne Marie McCarthy - Johns Hopkins Bloomberg School of Public Health...
Long term effects oophorectomy, at a young age, on bone health ( Dr Anne Marie McCarthy - Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA )
16 Dec 2011
Everolimus for postmenopausal women with advanced breast cancer
Dr Gabriel Hortobagyi - MD Anderson Cancer Center, Houston, Texas, USA
Everolimus for postmenopausal women with advanced breast cancer ( Dr Gabriel Hortobagyi - MD Anderson Cancer Center, Houston, Texas, USA )
16 Dec 2011
Randomized Phase II Study in Patients with HER2-Positive Breast Cancer
Dr Luca Gianni - Ospedale San Raffaele, Milan, Italy
Randomized Phase II Study in Patients with HER2-Positive Breast Cancer ( Dr Luca Gianni - Ospedale San Raffaele, Milan, Italy )
16 Dec 2011
Influence of age and BRCA status on contralateral breast cancer risk
Alexandra van den Broek - Netherlands Cancer Institute, Amsterdam
Influence of age and BRCA status on contralateral breast cancer risk ( Alexandra van den Broek - Netherlands Cancer Institute, Amsterdam )
16 Dec 2011
Novel agents and proteasome inhibitors in myeloma
Prof Michele Cavo - University of Bologna, Italy
Novel agents and proteasome inhibitors in myeloma ( Prof Michele Cavo - University of Bologna, Italy )
14 Dec 2011
Advances in peripheral T-cell lymphoma
Prof John Gribben – Barts and The London Trust, London and Prof Bertrand...
Advances in peripheral T-cell lymphoma ( Prof John Gribben – Barts and The London Trust, London and Prof Bertrand Coiffier - Hospices Civils de Lyon, France )
14 Dec 2011
Final results of the phase 3 VISTA trial: bortezomib-melphalan-prednisone (VMP)...
Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain
Final results of the phase 3 VISTA trial: bortezomib-melphalan-prednisone (VMP) vs melphalan-prednisone (MP) for multiple myeloma ( Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain )
14 Dec 2011
Translational research and proteasome inhibitors in multiple myeloma
Prof Kenneth Anderson - Dana-Farber Cancer Institute, Boston, USA
Translational research and proteasome inhibitors in multiple myeloma ( Prof Kenneth Anderson - Dana-Farber Cancer Institute, Boston, USA )
14 Dec 2011
CLEOPATRA trial to evaluate the efficacy and safety of pertuzumab + trastuzumab...
Prof Jose Baselga - Massachusetts General Hospital Cancer Center, Boston, MA
CLEOPATRA trial to evaluate the efficacy and safety of pertuzumab + trastuzumab + docetaxel ( Prof Jose Baselga - Massachusetts General Hospital Cancer Center, Boston, MA )
14 Dec 2011
Developments in proteasome inhibitors, transplant and myeloma research
Dr Keith Stewart - Mayo Clinic, Scottsdale Arizona, USA
Developments in proteasome inhibitors, transplant and myeloma research ( Dr Keith Stewart - Mayo Clinic, Scottsdale Arizona, USA )
14 Dec 2011
Cultural sensitivity in palliative care
Dr Deena Aljawi - King Faisai Specialist Hospital, Riyadh, Saudi Arabia
Cultural sensitivity in palliative care ( Dr Deena Aljawi - King Faisai Specialist Hospital, Riyadh, Saudi Arabia )
14 Dec 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation